Biocompatibility markers for the study of interactions between osteoblasts and composite biomaterials

Biomaterials

Volumn 30, Issue 1, 2009, Pages 45-51

  Alcaide, María ^a   Serrano, María Concepción ^a   Pagani, Raffaella ^a   Sánchez Salcedo, Sandra ^b,c   Vallet Regí, María ^b,c   Portolés, María Teresa ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Agarose; Biphasic calcium phosphate; Bone graft; Nitric oxide; Saos 2 osteoblasts

Indexed keywords

AGAROSE; APOPTOSIS; BIODEGRADABLE; BIPHASIC CALCIUM PHOSPHATE; BIPHASIC CALCIUM PHOSPHATES; BONE GRAFT; BONE GRAFT SUBSTITUTES; BONE SUBSTITUTIONS; CELL CYCLES; CELL FUNCTIONS; CELL NECROSES; CELL SIZES; CERAMIC COMPONENTS; COMPOSITE BIOMATERIALS; FLUORESCENT PROBES; MITOCHONDRIAL MEMBRANE POTENTIALS; PHOSPHATIDYLSERINE; PLASMA MEMBRANES; SAOS-2 OSTEOBLASTS; SYNTHASE; TRICALCIUM PHOSPHATES; VIABLE CELLS;

APATITE; BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BONE; BUILDING MATERIALS; CALCIUM; CALCIUM ALLOYS; CALCIUM PHOSPHATE; CELL CULTURE; CELL DEATH; CELL MEMBRANES; CELLS; CERAMIC MATERIALS; CYTOLOGY; DISKS (MACHINE COMPONENTS); DISKS (STRUCTURAL COMPONENTS); ENDOTHELIAL CELLS; FLOW INTERACTIONS; GRAFTING (CHEMICAL); GRAFTS; HYDROXYAPATITE; NITRIC OXIDE; OXIDES; PHOSPHATES; PHOTOLITHOGRAPHY; PLASMAS; SENSITIVITY ANALYSIS;

BIOMATERIALS;

BIOMATERIAL; CALCIUM PHOSPHATE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYAPATITE; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BONE GRAFT; CELL CULTURE; CELL CYCLE; CELL FUNCTION; CELL INTERACTION; CELL MEMBRANE; CELL SIZE; COMPOSITE MATERIAL; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANNEXIN A5; APOPTOSIS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; CELL CYCLE; CELL LINE, TUMOR; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NECROSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OSTEOBLASTS; PHOSPHATIDYLSERINES;

EID: 54049144161     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.09.012     Document Type: Article

References (28)

1. Wang X., Fan H., Xiao Y., and Xingdong Z. Fabrication and characterization of porous hydroxyapatite/β-tricalcium phosphate ceramics by microwave sintering. Mater Lett 60 (2006) 455-458
2. Dalcusi G. Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute. Biomaterials 19 (1998) 1473-1478
3. Yamada S., Heymann D., Bouler J.-M., and Dalcusi G. Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/β-tricalcium phosphate ratios. Biomaterials 18 (1997) 1037-1041
4. LeGeros R.Z., Lin S., Rohanizadeh R., Mijares D., and LeGeros J.P. Biphasic calcium phosphate bioceramics: preparation, properties and applications. J Mater Sci Mater Med 14 (2003) 201-209
5. Sánchez-Salcedo S., Izquierdo-Barba I., Arcos D., and Vallet-Regi M. In vitro evaluation of potential calcium phosphate scaffolds for tissue engineering. Tissue Eng (2006) 279-290
6. Cabañas M.V., Peña J., Román J., and Vallet-Regí M. Room temperature synthesis of agarose/sol-gel glass pieces with tailored interconnected porosity. J Biomed Mater Res A 78 (2006) 508-514
7. Román J., Cabañas M.V., Peña J., Doadrio J.C., and Vallet-Regí M. An optimized β-tricalcium phosphate and agarose scaffold fabrication technique. J Biomed Mater Res A 84 (2008) 99-107
8. Alcaide M., Serrano M.C., Pagani R., Sánchez-Salcedo S., Nieto A., Vallet-Regí M., et al. L929 fibroblast and Saos-2 osteoblast response to hydroxyapatite-βTCP/agarose biomaterial. J Biomed Mater Res A (2008) 10.1002/jbm.a.31985
9. Sánchez-Salcedo S., Nieto A., and Vallet-Regí M. Hydroxyapatite/ß-tricalcium phosphate/agarose macroporous scaffolds for bone tissue engineering. Chem Eng J 137 (2008) 62-71
10. Darzynkiewicz Z., Juan G., and Bedner E. Determining cell cycle stages by flow cytometry. Curr Protoc Cell Biol (2001 May) [chapter 8:Unit8.4]
11. Facompré M., Wattez N., Kluza J., Lansiaux A., and Bailly C. Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide. Mol Cell Biol Res Commun 4 (2000) 37-42
12. Nishimura D., Ishikawa H., Matsumoto K., Shibata H., Motoyoshi Y., Fukuta M., et al. DHMEQ, a novel NF-κB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells. Int J Oncol 29 (2006) 713-719
13. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., and Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148 (1992) 22-29
14. Koopman G., Reutelingsperger C.P.M., Kuijten G.A.M., Keehnen R.M.J., Pals S.T., and van Oers M.H.J. Annexin V for flow cytometric detection of phosphatidylserine expression of B cells undergoing apoptosis. Blood 84 (1994) 1415-1420
15. van Engeland M., Nieland L.J.W., Ramaekers F.C.S., Schutte B., and Reutelingspaper P.M. Annexin V-affinity assay: a review on an apoptosis detection detection system based on phosphatidylserine exposure. Cytometry 31 (1998) 1-9
16. Koshkaryev A., Yedgar S., Relevy H., Fibach E., and Barshtein G. Acridine orange induces translocation of phosphatidylserine to red blood cell surface. Am J Physiol Cell Physiol 285 (2003) C720-C722
17. Mignotte B., and Vayssiere J.-L. Mitochondria and apoptosis. Eur J Biochem 252 (1998) 1-15
18. Floryk D., and Houstek J. Tetramethyl rhodamine methyl ester (TMRM) is suitable for cytofluorometric measurements of mitochondrial membrane potential in cells treated with digitonin. Biosci Rep 19 (1999) 27-34
19. Hortelano S., Través P.G., Zeini M., Álvarez A.M., and Boscá L. Sustained nitric oxide delivery delays nitric oxide-dependent apoptosis in macrophages: contribution to the physiological function of activated macrophages. J Immunol 171 (2003) 6059-6064
20. Kanduc D., Mittelman A., Serpico R., Sinigaglia E., Sinha A.A., Natale C., et al. Cell death: apoptosis versus necrosis. Int J Oncol 21 (2002) 165-170
21. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 (2004) 205-219
22. Moncada S., Palmer R.M., and Higos E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43 (1991) 109-142
23. Collin-Osdoby P., Nickols G.A., and Osdoby P. Bone cell function, regulation, and communication: a role for nitric oxide. J Cell Biochem 57 (1995) 399-408
24. Nakatsubo N., Kojima H., Kikuchi K., Nagoshi H., Hirata Y., Maeda D., et al. Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofluoresceins. FEBS Lett 427 (1998) 263-266
25. van't Hof R.J., and Ralston S.H. Nitric oxide and bone. Immunology 103 (2001) 255-261
26. Kenneth J., Armour K.E., vańT Hof R.J., Reid D.M., Wei X.-Q., Liew F.Y., et al. Activation of the inducible nitric synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum 44 (2001) 2790-2796
27. Aguirre J., Buttery L., ÓShaughnessy M., Afzal F., Fernández de Marticorena I., Hukkanen M., et al. Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation reduced bone volume, defects in osteoblast maturation activity. Am J Pathol 158 (2001) 247-257
28. Corbett S.A., Hukkanen M., Batten J., McCarthy I.D., Polak J.M., and Hughes S.P.F. Nitric oxide in fracture repair. J Bone Joint Surg (Br) 81-B (1999) 531-537